The World Health Organization (WHO) has waded into the issue of reinfection saying, “there is no evidence patients who recovered from Coronavirus can’t get reinfected”.
WHO in a statement shared on Friday, said that though there are suggestion the detection of antibodies could serve as the basis for an “immunity passport” or “risk-free certificate”, it will however continue reviewing the evidence on antibody responses to the infection.
Parts of the statement read; “Most of these studies show that people who have recovered from infection have antibodies to the virus. However, some of these people have very low levels of neutralizing antibodies in their blood, suggesting that cellular immunity may also be critical for recovery.
“As of 24 April 2020, no study has evaluated whether the presence of antibodies to SARS-CoV-2 confers immunity to subsequent infection by this virus in humans.
“Laboratory tests that detect antibodies to SARS-CoV-2 in people, including rapid immunodiagnostic tests, need further validation to determine their accuracy and reliability. Inaccurate immunodiagnostic tests may falsely categorize people in two ways.
“The first is that they may falsely label people who have been infected as negative, and the second is that people who have not been infected are falsely labelled as positive. Both errors have serious consequences and will affect control efforts.
“These tests also need to accurately distinguish between past infections from SARS-CoV-2 and those caused by the known set of six human coronaviruses. Four of these viruses cause the common cold and circulate widely. The remaining two are the viruses that cause Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome. People infected by any one of these viruses may produce antibodies that cross-react with antibodies produced in response to infection with SARS-CoV-2.”
The global health body stated that some governments who want a gradual return to work and the resumption of economic activity, have put forward the idea of issuing documents attesting to the immunity of people on the basis of serological tests revealing the presence of antibodies in the blood. It however added that the serological tests currently used “need additional validation to determine their accuracy and reliability”.
It further stated that though it supports studies that will provide data on the percentage of people with detectable COVID-19 antibodies, however most of them are not designed to determine whether those people are immune to secondary infections.